The influence of different sugammadex doses on neural tube development in early‐stage chick embryos
Birth Defects Research · 2023
DOI: 10.1002/bdr2.2237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research, 2023. Verfasst von Asude Ayhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Reanimation, Baskent University School of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: Neural Tube, Neural Tube Defects, Sugammadex. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Background
Sugammadex is a modified gamma‐cyclodextrin that has been developed with the goal of reversing the steroidal neuromuscular blocking agents. The aim of the present study is to investigate the effects of different sugammadex doses on embryologic and neural tube development in an early‐stage chick embryo model.
Methods
A total of 100 specific pathogen‐free, fertilized domestic chicken eggs were randomly divided into five groups ( n = 20, each), and placed in an automatic cycle incubator. The eggs in the “control (C)” group were incubated without administration of any drug till the end of the experiment. Sub‐blastodermic administration of 0.9% NaCl as vehicle control (VC) and different doses of sugammadex solutions prepared with the latter [2 mg/mL (LD), 4 mg/mL (MD), 16 mg/mL (HD)] were performed at 30 hr of incubation. All embryos were removed from the eggs at 72 hr when they were expected to reach Hamburger‐Hamilton (HH) stages 19–20, then they were fixed, and evaluated histo‐morphologically.
Results
Embryonic development was not observed in 11 eggs (1 in C, 1 in VC; 3 in LD, 3 in MD, and 3 in HD). All the developed embryos were compatible with the HH stages 19–20. A neural tube closure defect was detected in one embryo in the HD group. No statistically significant difference was found between the groups in terms of embryonic and neural tube developments.
Conclusions
No significant association was found between the drug and adverse outcomes; however, a trend with dosing was seen. Further studies are required before conclude on safety and extrapolate these results to human beings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology and Reanimation, Baskent University School of Medicine, Ankara, Turkey.
- Department of Histology and Embryology, Baskent University School of Medicine, Ankara, Turkey.
- Department of Pharmacology, Baskent University School of Medicine, Ankara, Turkey.
- Department of Biostatistics, Baskent University School of Medicine, Ankara, Turkey.
- Institutional Big Data Management Unit, Middle East Technical University, Ankara, Turkey.
- Department of Neurological Surgery, Baskent University School of Medicine, Ankara, Turkey.
ORCID-Profile: Asude Ayhan, Ekin Efe, Pinar A Fidan, Oguzhan E Efe, Eylem Gul Ates, Fikret Sahinturk, Selim Ayhan
Zitieren
APA
Ayhan, A., Efe, E., Fidan, P. A., Efe, O. E., Ates, E. G., Sahinturk, F., & Ayhan, S. (2023). The influence of different sugammadex doses on neural tube development in early‐stage chick embryos. Birth Defects Research. https://doi.org/10.1002/bdr2.2237
Vancouver
Ayhan A, Efe E, Fidan PA, Efe OE, Ates EG, Sahinturk F, et al. The influence of different sugammadex doses on neural tube development in early‐stage chick embryos. Birth Defects Research. 2023. doi:10.1002/bdr2.2237
BibTeX
@article{Ayhan2023,
author = {Ayhan, Asude and Efe, Ekin and Fidan, Pinar A and Efe, Oguzhan E and Ates, Eylem Gul and Sahinturk, Fikret and Ayhan, Selim},
title = {The influence of different sugammadex doses on neural tube development in early‐stage chick embryos},
journal = {Birth Defects Research},
year = {2023},
doi = {10.1002/bdr2.2237}
}
EUVIMED